Breaking Through Calcific in-Stent Restenosis
- PMID: 37704467
- DOI: 10.1016/j.amjcard.2023.08.133
Breaking Through Calcific in-Stent Restenosis
Conflict of interest statement
Declaration of Competing Interest J. Dawn Abbott reports a relationship with Medtronic that includes consulting or advisory, with Abbott that includes consulting or advisory, with Boston Scientific Corp that includes funding grants, with Med Alliance that includes funding grants, with Microport that includes funding grants, with Penumbra Inc that includes consulting or advisory, and with Shockwave Medical Inc that includes consulting or advisory. Editorial Board AJC, J. Dawn Abbott MD.
Comment on
-
Rotational Atherectomy Versus Intravascular Lithotripsy for Calcified In-Stent Restenosis: A Single-Center Study With 1-Year Follow-Up.Am J Cardiol. 2023 Oct 15;205:413-419. doi: 10.1016/j.amjcard.2023.07.174. Epub 2023 Aug 31. Am J Cardiol. 2023. PMID: 37659262
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources